Montes Archimedes Acquisition Corp. announced the pricing of its downsized $400 million IPO last night and the units are expected to begin trading on the Nasdaq under the symbol “MAACU” today, Wednesday, October 7.
This new company aims to combine with a company that serves a critical role in the healthcare ecosystem and has the potential for durable revenue. Montes Archimedes is led by CEO and Director James C. Momtazee and CEO Maria C. Walker.
Total SPAC deal count for 2020 year-to-date is now 132 with $50.62 billion in gross proceeds raised. This offering is expected to close on Friday, October 9.
Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the offering. Kirkland & Ellis LLP is serving as Issuer’s Counsel with Ropes & Gray LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company LLC is acting as trustee.